We support the engagement of all relevant international organizations, such as WHO, and initiatives, including the recent expansion of the Medicines Patent Pool, in their work to improve access for all to safe, effective, quality, affordable and essential health products.
G7 Health Ministerial Session
Since 2012, the Medicines Patent Pool (MPP) has become the main driving force behind quality, proactive voluntary licensing in the pharmaceutical industry (see Figure 30). The Foundation has consistently found that the transparency and flexibility of terms and conditions is highest when the MPP is involved.
Access to Medicine Foundation report
I am honoured to be invited to represent the WHO on the MPP’s Governance Board. Access to essential medicines is fundamental to the ability of everyone to achieve the highest attainable standard of health and core to the Sustainable Development Goal of promoting well-being for all at all ages. I look forward to contributing to the MPP’s development in this area.
Dr Mariângela Batista Galvão Simão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, the World Health Organization